MAPK3 and prostate carcinoma: This is consistent with a previous report demonstrating that ERK1/2 is not involved in EGF-induced migration of prostate cancer cell line DU14546 and suggests that the PI3K-C2β-regulation of MEK/ERK is involved in steps necessary for cell invasion other than cell migration.